Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile

Dec-06

AUTHORS : Dr Marianne Yood (Details for study: Yale University School of Medicine), Boston University School of Public Health, 715 Albany St Talbot Building, Boston MA 02118 – Email: muyood@bu.edu – Profile: https://profiles.bu.edu/Marianne.Yood – Contact is Felix Arellano but he is now Global Head of Drug Safety at Roche and I cannot find his contact details

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 15(12):861-72

DOI : 10.1002/pds.1343

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile

More publications

Association Between Type 2 Diabetes Onset Age and Risk of Cardiovascular Disease and Mortality: Two Cohort Studies from United Kingdom and Hong Kong

Characteristics of Patients With Atherosclerotic Cardiovascular Disease in Belgium and Current Treatment Patterns for the Management of Elevated LDL-C Levels

Unveiling unique clinical phenotypes of hip fracture patients and the temporal association with cardiovascular events